Utility of MIB-1 and estrogen and progesterone receptor in distinguishing between endometrial stromal sarcomas and endometrial stromal nodules, highly cellular leiomyomas

International Journal of Gynecological Cancer

Volumn 15, Issue 2, 2005, Pages 337-342

  Kir, G ^a,c   Cetiner, H ^a   Karateke, A ^a   Gurbuz, A ^a   Bulbul, D ^b  

^a Zeynep Kamil Maternity Hospital   (Turkey)

^b SSK Ankara Maternity Hospital   (Turkey)

^c Sinpas Aqua Manors Sitesi D 18   (Turkey)

Author keywords

Endometrial stromal sarcoma; Estrogen receptor; MIB 1; Progesterone receptor

Indexed keywords

BIOLOGICAL MARKER; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIUM SARCOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TISSUE SECTION; UTERUS MYOMA;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; CURETTAGE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LEIOMYOMA; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; SARCOMA, ENDOMETRIAL STROMAL; TUMOR MARKERS, BIOLOGICAL; UTERINE DISEASES; UTERINE NEOPLASMS;

EID: 15444369903     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.15226.x     Document Type: Article

References (24)

1. Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL, Hendrickson MR. Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. Am J Surg Pathol 1990;14:415-38.
2. Dionigi A, Oliva E, Clement PB, Young RH. Endometrial stromal nodules and endometrial stromal tumors with limited infiltration. A clinicopathologic study of 50 cases. Am J Surg Pathol 2002;26:567-81.
3. Oliva E, Young RH, Clement PB, Bhan AK, Scully RE. Cellular benign mesencymal tumors of the uterus. A comparative morphologic and immunohistochemical analysis of 33 highly cellular leiomyomas and six endometrial stromal nodules, two frequently confused tumors. Am J Surg Pathol 1995;19:757-68.
4. Rush DS, Tan JY, Baergen RN, Soslow RA. h-Caldesmon, a novel smooth muscle-specific antibody, distinguish between cellular leiomyoma and endometrial stromal sarcoma. Am J Surg Pathol 2001;25:253-8.
5. Chu PG, Arber DA, Weiss LM, Chang KL. Utility of CD 10 distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases. Mod Pathol 2001;14:465-71.
6. Nucci MR, O'Connel JT, Huettner PC, Cviko A, Quade BJ. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors. Am J Surg Pathol 2001;25:455-63.
7. Franquemont DW, Frierson HF, Mills SE. An immunohistochemical study of normal endometrial stroma and endometrial stromal neoplasms. Evidence for smooth muscle differentiation. Am J Surg Pathol 1991;15:861-70.
8. Farhood AI, Abrams J Immunohistochemistry of endometrial stromal sarcoma. Hum Pathol 1991;22:224-30.
9. Agoff SN, Grieco VS, Garcia R, Gown AM. Immunohistochemical distinction of endometrial stromal sarcoma and cellular leiomyoma. Appl Immunohistochem Mol Morphol 2001;9:164-9.
10. McClugge WG, Sumathi VP, Maxwell P. CD 10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 2001;39:273-8.
11. Toki T, Shimizu M, Takagi Y, Ashida T, Konishi I. CD 10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol 2002;21:41-7.
12. Oliva E, Young RH, Amin MB, Clement PB. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus. A study of 54 cases emphasizing the importance of using a individual antibodies. Am J Surg Pathol 2002;26:403-12.
13. Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T, Sugimori H. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol Oncol 1998;69:220-5.
14. Kounelis S, Kapranos N, Kouri E, Coppola D, Papadaki H, Jones MW. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature. Mod Pathol 2000;13:379-88.
15. Zhai YL, Kobayashi Y, Mori A. Expression of steroid receptors, Ki-67, and p 53 in utreine leiomyosarcomas. Int J Gynecol Pathol 1999;18:20-8.
16. Amadra S, Nakamo H, Tsuneyoshi M. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p 53 expression, DNA flow cytometry and muscle specific actins. Int J Gynecol Pathol 1995;14:134-42.
17. Mittal K, Demopoulos RI. MIB-1 (Ki-67), p 53, estrogen receptor, and progesteron receptor expression in uterine smooth muscle tumors. Hum Pathol 2001;32:984-7.
18. Yavuz E, Gulluoglu MG, Akbas N et al. The values of intratumoral mast cell count and Ki-67 immunoreactivity index in differential diagnosis of uterine smooth muscle neoplasms. Pathol Int 2001;51:938-41.
19. Carcangiu ML, Chambers JT, Voynick IM, Pirro M, Schwartz PE. Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: clinical and histologie correlations. Am J Clin Pathol 1990;94:247-54.
20. Popiolek D, Yee H, Levine P, Vamvakas E, Demopoulos RI. MIB 1 as a possible predictor of recurrence in low-grade endometrial stromal sarcoma of the uterus. Gynecol Oncol 2003;90:353-7.
21. Reich O, Regauer S, Urdi W, Lahousen M, Winter R. Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer 2000;82:1030-4.
22. Cku MC, Mor G, Lim C, Zheng W, Parkash V, Schwartz PE. Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 2003;90:170-6.
23. Aubry MC, Myers JL, Colby TV, Leslie KO, Tazelaar HD. Endometrial stromal sarcoma metastatic to the lung. A detailed analysis of 16 patients. Am J Surg Pathol 2002;26:440-9.
24. Kasashima S, Kobayashi M, Yamada M, Oda Y. Myxoid endometrial stromal sarcoma of the uterus. Pathol Int 2003;53:637-41.